phosphites has been researched along with bisphenol a in 1 studies
| Studies (phosphites) | Trials (phosphites) | Recent Studies (post-2010) (phosphites) | Studies (bisphenol a) | Trials (bisphenol a) | Recent Studies (post-2010) (bisphenol a) |
|---|---|---|---|---|---|
| 515 | 0 | 231 | 7,618 | 33 | 5,736 |
| Protein | Taxonomy | phosphites (IC50) | bisphenol a (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 1.2263 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 2 | |
| Androgen receptor | Homo sapiens (human) | 5.9 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.304 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 5.42 | |
| Estrogen-related receptor gamma | Homo sapiens (human) | 0.009 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bercu, J; Binazon, O; Broschard, T; Bruen, U; Callis, CM; Cruz, MT; Dolan, DG; Erexson, GL; Giddings, A; Glowienke, S; Li, K; Martin, EA; Masuda-Herrera, M; Nagao, LM; Parris, P; Stanard, B; Stults, CLM; Whelan, G | 1 |
1 other study(ies) available for phosphites and bisphenol a
| Article | Year |
|---|---|
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
Topics: Animals; Benzhydryl Compounds; Butylated Hydroxytoluene; Cricetinae; Decision Trees; Drug Contamination; Drug Packaging; Humans; Mice; Patient Safety; Pharmaceutical Preparations; Phenols; Phosphites; Rats; Risk Assessment; Toxicity Tests; Toxicokinetics | 2020 |